when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

pharmadog
calendar
approval

approval

DYANAVEL XR (AMPHETAMINE) — FDA approval

October 13, 2023$TRAW amfetamine ERupdated 5mo ago

community read0 votes

Sponsor: TRIS PHARMA INC. Form: SUSPENSION, EXTENDED RELEASE. Route: ORAL

view source ↗

Data sources

last refreshed 5mo ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

drug timeline · 8

approvalAMPHETAMINE SULFATE — FDA approvalSep 26, 2025 · 373d ago
approvalAMPHETAMINE SULFATE — FDA approvalSep 26, 2025 · 373d ago
approvalDYANAVEL XR (AMPHETAMINE) — FDA approvalSep 23, 2025 · 376d ago
approvalAMPHETAMINE SULFATE — FDA approvalOct 17, 2023 · 1083d ago
approvalAMPHETAMINE SULFATE — FDA approvalOct 13, 2023 · 1087d ago
approvalDYANAVEL XR (AMPHETAMINE) — FDA approvalJun 1, 2022 · 1586d ago
approvalAMPHETAMINE SULFATE — FDA approvalFeb 25, 2022 · 1682d ago
approvalDYANAVEL XR (AMPHETAMINE) — FDA approvalFeb 25, 2022 · 1682d ago

same company · ±60 days · 2

approvalADZENYS XR-ODT (AMPHETAMINE) — FDA approvalOct 13, 2023
approvalDYANAVEL XR 20: DYANAVEL XR 20 (AMPHETAMINE) — FDA approvalOct 13, 2023

🐶 often sniffed alongside

top 6

drugDYANAVEL XR 2028 co-mentions · 14 sources
drugDYANAVEL XR28 co-mentions · 14 sources
tagApproval28 co-mentions · 14 sources
drugamfetamine ER-ODT14 co-mentions · 14 sources
companyTris Pharma Inc14 co-mentions · 14 sources
tagSmall Molecule14 co-mentions · 14 sources

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?